Wound Dehiscence or Failure to Heal following Venous Access Port Placement in Patients Receiving Bevacizumab Therapy

Wound dehiscence after port placement was related to timing of bevacizumab therapy. Patients receiving bevacizumab within 10 days of port placement had a higher incidence of wound dehiscence.